Llovet, Josep M. https://orcid.org/0000-0003-0547-2667
Article History
First Online: 30 June 2025
Competing interests
: J.M.L. receives consulting fees from AbbVie, AstraZeneca, Bayer HealthCare Pharmaceuticals, Bristol-Myers Squibb, Eisai, Genentech, Glycotest, Merck, Roche and Sanofi Aventis, and research support from Eisai.